Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AI Labs Group S.L
Brain Inflammation Collaborative
Cairo University
Brigham and Women's Hospital
Bristol-Myers Squibb
M.D. Anderson Cancer Center
Amgen
Leiden University Medical Center
ProgenaBiome
Pfizer
HJN Sverige AB/Neko Health
University of California, Davis
Bristol-Myers Squibb